We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ARX-FLUTICASONE (Helix Pharmaceuticals Pty Ltd)
Product name
ARX-FLUTICASONE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
123 (255 working days)
Active ingredients
fluticasone furoate
Registration type
New generic medicine
Indication
For the treatment of seasonal allergic rhinitis and perennial allergic rhinitis in adults and children of ages 2 years and older.